Patents by Inventor Brian Stearns
Brian Stearns has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240060300Abstract: Implementations described and claimed herein provide for modular snow and ice retention and mounting systems. In various embodiments, a bracket may comprise a mounting strap, a hybrid pad, a bracket assembly and a rod. The hybrid pad may comprise a face portion and a support portion. The face portion and the support portion may be operatively coupled together. The hybrid pad may be operatively coupled to the mounting strap. The face portion may comprise a stiffening rib. The stiffening rib may be defined in a front surface of the face portion. The stiffening rib may define a first load plane. The face portion may also define a first rod notch. The first rod notch may be defined on a first side of the face portion. The face portion may also define a second rod notch. The rod may be mountable to the hybrid pad.Type: ApplicationFiled: February 16, 2023Publication date: February 22, 2024Inventors: Brian Stearns, Kris Michaud
-
Patent number: 11850178Abstract: A supportive brace to be worn circumferentially around the forearm for preventing and reducing pain and discomfort associated with epicondylitis (Tennis Elbow or Golfer's Elbow) of the elbow is disclosed. The brace includes a padded counterforce strap assembly band circumferentially fitted around the forearm. The strap assembly has an elastomeric buttress positioned to apply targeted compression to the ECRB. A toric ring forms a cushioned border around the concavity on the dorsal face of the elastomeric buttress, so that when the band is fittingly secured around the forearm about 1-1.5 in distal to either of the epicondyles, the hemispherical/ovaloid convex shape on the inside face of the elastomeric buttress exerts controlled pressure to tissues associated with the epicondylitis.Type: GrantFiled: June 8, 2021Date of Patent: December 26, 2023Inventor: Jeffrey Brian Stearns
-
Publication number: 20230349159Abstract: The present disclosure relates to ice retention assemblies for buildings. The ice retention assemblies may comprise a body, a seal and a fastener. The body may have a base portion and a top portion. The top portion may be removable from the base portion. The base portion may defining a channel that is configured to receive a fastener. The base portion may have a generally planar bottom surface. The base portion may also comprise a sealing recess that is shaped to receive a seal. The seal may be installable in the sealing recess of the base portion. A fastener may be installable through at least a portion of the base portion. The fastener may be configured to compress the base portion and the seal against a surface.Type: ApplicationFiled: April 27, 2023Publication date: November 2, 2023Inventors: Brian Stearns, Kris Michaud, Crystal Fletcher, Matthew Duncan
-
Patent number: 11758883Abstract: The present disclosure is directed to systems and methods for training animals using a wirelessly activated scent-based training system. The scent-based training system includes a reward dispenser that holds a reward. The scent-based training system also includes a scent chamber physically couplable to a target scent reservoir. Target scent molecules flow from the scent reservoir to the interior space of the scent chamber where they may be detected by the animal at which time a reward may be dispensed. The reward passes through the scent chamber prior to being provided to the animal. The reward “pushes” air through the scent chamber prior to passage through the chamber, increasing the concentration of target scent molecules proximate the scent chamber. After passage through the scent chamber a venturi effect created by the reward causes additional target scent molecules to flow from the target scent reservoir to the scent chamber.Type: GrantFiled: November 1, 2022Date of Patent: September 19, 2023Assignee: CANINE DETECTION SERVICES LLCInventors: Frederick Helfers, III, Brian Stearns
-
Patent number: 11624188Abstract: Implementations described and claimed herein provide for modular snow and ice retention and mounting systems. In various embodiments, a bracket may comprise a mounting strap, a hybrid pad, a bracket assembly and a rod. The hybrid pad may comprise a face portion and a support portion. The face portion and the support portion may be operatively coupled together. The hybrid pad may be operatively coupled to the mounting strap. The face portion may comprise a stiffening rib. The stiffening rib may be defined in a front surface of the face portion. The stiffening rib may define a first load plane. The face portion may also define a first rod notch. The first rod notch may be defined on a first side of the face portion. The face portion may also define a second rod notch. The rod may be mountable to the hybrid pad.Type: GrantFiled: February 3, 2021Date of Patent: April 11, 2023Assignee: Vermont Slate & Copper Services, Inc.Inventors: Brian Stearns, Kris Michaud
-
Publication number: 20230058034Abstract: The present disclosure is directed to systems and methods for training animals using a wirelessly activated scent-based training system. The scent-based training system includes a reward dispenser that holds a reward. The scent-based training system also includes a scent chamber physically couplable to a target scent reservoir. Target scent molecules flow from the scent reservoir to the interior space of the scent chamber where they may be detected by the animal at which time a reward may be dispensed. The reward passes through the scent chamber prior to being provided to the animal. The reward “pushes” air through the scent chamber prior to passage through the chamber, increasing the concentration of target scent molecules proximate the scent chamber. After passage through the scent chamber a venturi effect created by the reward causes additional target scent molecules to flow from the target scent reservoir to the scent chamber.Type: ApplicationFiled: November 1, 2022Publication date: February 23, 2023Applicant: CANINE DETECTION SERVICES LLCInventors: Frederick Helfers, III, Brian Stearns
-
Publication number: 20210310205Abstract: Implementations described and claimed herein provide for modular snow and ice retention and mounting systems. In various embodiments, a bracket may comprise a mounting strap, a hybrid pad, a bracket assembly and a rod. The hybrid pad may comprise a face portion and a support portion. The face portion and the support portion may be operatively coupled together. The hybrid pad may be operatively coupled to the mounting strap. The face portion may comprise a stiffening rib. The stiffening rib may be defined in a front surface of the face portion. The stiffening rib may define a first load plane. The face portion may also define a first rod notch. The first rod notch may be defined on a first side of the face portion. The face portion may also define a second rod notch. The rod may be mountable to the hybrid pad.Type: ApplicationFiled: February 3, 2021Publication date: October 7, 2021Inventors: Brian Stearns, Kris Michaud
-
Publication number: 20210176963Abstract: The present disclosure is directed to systems and methods for training animals using a wirelessly activated scent-based training system. The scent-based training system includes a reward dispenser that holds a reward. The scent-based training system also includes a scent chamber physically couplable to a target scent reservoir. Target scent molecules flow from the scent reservoir to the interior space of the scent chamber where they may be detected by the animal at which time a reward may be dispensed. The reward passes through the scent chamber prior to being provided to the animal. The reward “pushes” air through the scent chamber prior to passage through the chamber, increasing the concentration of target scent molecules proximate the scent chamber. After passage through the scent chamber a venturi effect created by the reward causes additional target scent molecules to flow from the target scent reservoir to the scent chamber.Type: ApplicationFiled: December 16, 2020Publication date: June 17, 2021Applicant: CANINE DETECTION SERVICES LLCInventors: Frederick Helfers, III, Brian Stearns
-
Patent number: 9267698Abstract: A mister fan includes a base, a motor supported by the base, a blade assembly supported by the base and driven by the motor, a first conduit extending from the base and configured to receive liquid from a first fluid source, and a second conduit extending from the base and configured to receive liquid from a second fluid source that is different than the first fluid source. The mister fan also includes a spray nozzle unit supported by the base adjacent the blade assembly. The spray nozzle unit is in fluid communication with the first conduit and the second conduit to selectively receive liquid from the first and second conduits.Type: GrantFiled: February 28, 2014Date of Patent: February 23, 2016Assignee: Techtronic Power Tools Technology LimitedInventor: Brian Stearns
-
Publication number: 20150247644Abstract: A mister fan includes a base, a motor supported by the base, a blade assembly supported by the base and driven by the motor, a first conduit extending from the base and configured to receive liquid from a first fluid source, and a second conduit extending from the base and configured to receive liquid from a second fluid source that is different than the first fluid source. The mister fan also includes a spray nozzle unit supported by the base adjacent the blade assembly. The spray nozzle unit is in fluid communication with the first conduit and the second conduit to selectively receive liquid from the first and second conduits.Type: ApplicationFiled: February 28, 2014Publication date: September 3, 2015Inventor: Brian Stearns
-
Patent number: 7910561Abstract: The present invention is directed to compounds which contain substituted naphthyridines which inhibit the activity of Akt, a serine/threonine protein kinase. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for treating cancer comprising administration of the compounds of the invention. These substituted naphthyridines have unexpected advantageous properties when compared to other naphthyridines reported in PCT publication WO2003/086394, such unexpected advantageous properties may include increased cellular potency/solubility, greater selectivity, enhanced pharmacokinetic properties, lack of off target activity and so on.Type: GrantFiled: December 9, 2005Date of Patent: March 22, 2011Assignee: Merck Sharp & Dohme Corp.Inventors: Jeannie M. Arruda, Brian T. Campbell, Nicholas D. P. Cosford, Jacob M. Hoffman, Essa H. Hu, Mark E. Layton, Yiwei Li, Jun Liang, Kevin J. Rodzinak, Tony Siu, Brian A. Stearns, Lida R. Tehrani, Mark T. Bilodeau, Peter J. Manley
-
Patent number: 7687541Abstract: The invention encompasses the novel compounds of Formula (I) and Formula (II), which are prodrugs that convert in vivo to diaryl-2-(5H)-furanones useful in the treatment of cyclooxygenase-2 mediated diseases. These prodrugs are far more soluble in aqueous media than the active agents into which they convert, in vivo. As such compounds of Formula (I) and (II) are advantageous for, among other things intravenous administration. The invention also encompasses certain pharmaceutical compositions and methods for treatment of cyclooxygenase-2 mediated diseases comprising the use of compounds of Formula (I) and Formula (II).Type: GrantFiled: October 18, 2004Date of Patent: March 30, 2010Assignee: Merck & Co., Inc.Inventors: Jeannie M. Arruda, Benito Munoz, Brian A. Stearns
-
Patent number: 7465730Abstract: 6H-pyrrolo[3,4-d]pyridazine compounds and methods of their use of as ligands of voltage gated calcium channels (VGCC), useful in the treatment of neuropathic pain, and psychiatric and mood disorders such as, for example, schizophrenia, anxiety, depression, panic, and bipolar disorder, as well as in the treatment of pain, Parkinson's disease, cognitive dysfunction, epilepsy, circadian rhythm disorders, drug addiction, drug abuse, drug withdrawal and other.Type: GrantFiled: July 8, 2003Date of Patent: December 16, 2008Assignee: Merck & Co. Inc.Inventors: Naomi Burke Anker, Jeannie M. Arruda, Brian Thomas Campbell, Benito Munoz, Petpiboon Prasit, Brian A. Stearns, Tao Hu
-
Patent number: 7462619Abstract: In accordance with the present invention, there is provided a novel class of heterocyclic compounds. Compounds of the invention contain a substituted or unsubstituted six membered heterocyclic ring that includes at least two nitrogen atoms. The ring additionally includes four carbon atoms. The heterocyclic ring has at least one substituent located at a ring position adjacent to a ring nitrogen atom. This mandatory substituent of the ring includes a moiety (B), linked to the heterocyclic ring via a carbon-carbon triple bond. The mandatory substituent is positioned adjacent to the ring nitrogen atom. Invention compounds are capable of a wide variety of uses. For example heterocyclic compounds can act to modulate physiological processes by functioning as agonists and antagonists of receptors in the nervous system. Invention compounds may also act as insecticides, and as fungicides. Pharmaceutical compositions containing invention compounds also have wide utility.Type: GrantFiled: April 1, 2005Date of Patent: December 9, 2008Assignee: Merck & Co., Inc.Inventors: Nicholas D. Cosford, Jeffrey R. Roppe, Lida R. Tehrani, Nicholas D. Smith, Brian Stearns, Dehua Huang, Bowei Wang, Thomas J. Seiders
-
Publication number: 20080287457Abstract: The present invention is directed to compounds which contain substituted naphthyridines which inhibit the activity of Akt, a serine/threonine protein kinase. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for treating cancer comprising administration of the compounds of the invention. These substituted naphthyridines have unexpected advantageous properties when compared to other naphthyridines reported in PCT publication WO2003/086394, such unexpected advantageous properties may include increased cellular potency/solubility, greater selectivity, enhanced pharmacokinetic properties, lack of off target activity and so on.Type: ApplicationFiled: December 9, 2005Publication date: November 20, 2008Inventors: Jeannie M. Arruda, Brian T. Campbell, Nicholas D.P. Cosford, Jacob M. Hoffman, Essa H. Hu, Mark E. Layton, Yiwei Li, Jun Liang, Kevin J. Rodzinak, Tony Siu, Brian A. Stearns, Lida R. Tehrani, Mark T. Bilodeau, Peter J. Manley
-
Patent number: 7365074Abstract: In accordance with the present invention, there is provided a novel class of heterocyclic compounds. Compounds of the invention contain a substituted, unsaturated five, six or seven membered heterocyclic ring that includes at least one nitrogen atom and at least one carbon atom. The ring additionally includes three, four or five atoms independently selected from carbon, nitrogen, sulfur and oxygen atoms. The heterocyclic ring has at least one substituent located at a ring position adjacent to a ring nitrogen atom. This mandatory substituent of the ring includes a moiety (B), linked to the heterocyclic ring via a carbon-carbon double bond, a carbon-carbon triple bond or an azo group. The mandatory substituent is positioned adjacent to the ring nitrogen atom. Invention compounds are capable of a wide variety of uses. For example heterocyclic compounds can act to modulate physiological processes by functioning as agonists and antagonists of receptors in the nervous system.Type: GrantFiled: June 23, 2004Date of Patent: April 29, 2008Assignee: Merck & Co., Inc.Inventors: Nicholas D. Cosford, Jeffrey R. Roppe, Lida R. Tehrani, Nicholas D. Smith, Brian Stearns, Dehua Huang, Bowei Wang
-
Publication number: 20070219206Abstract: Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of 5-lipoxygenase-activating protein (FLAP). Also described herein are methods of using such FLAP modulators, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other leukotriene-dependent or leukotriene mediated conditions or diseases.Type: ApplicationFiled: May 4, 2007Publication date: September 20, 2007Applicant: AMIRA PHARMACEUTICALS, INC.Inventors: John Hutchinson, Petpiboon Prasit, Mark Moran, Jillian Evans, Brian Stearns, Jeffrey Roppe, Bowei Wang, Yen Truong, Yiwei Li, Jasmine Zunic, Jeannie Arruda, Nicholas Stock, Mustapha Haddach, Thomas Seiders, Jill Scott
-
Patent number: D946769Type: GrantFiled: June 24, 2020Date of Patent: March 22, 2022Inventor: Jeffrey Brian Stearns
-
Patent number: D974161Type: GrantFiled: May 19, 2021Date of Patent: January 3, 2023Assignee: Vermont Slate & Copper Services, Inc.Inventors: Brian Stearns, Kris Michaud
-
Patent number: D1019374Type: GrantFiled: January 3, 2023Date of Patent: March 26, 2024Assignee: Vermont Slate & Copper Services, Inc.Inventors: Brian Stearns, Kris Michaud